The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.

The risk to the general public from bird flu is low, and there has been no further evidence of person to person spread, ...

Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...

The US Department of Health and Human Services has decided to spend nearly $600 million on the development of a bird flu ...

Moderna receives $590M contract from HHS for mRNA-based bird flu vaccine; up 4% in after-hours trading. Read more here.

Nationally, this avian flu sickened at least 66 people in 2024, mostly dairy farmworkers who came in contact with diseased ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

HHS Allocates $590 Million to Speed Up the Development of mRNA Vaccines for Pandemic Influenza, Including an H5N1 (Bird Flu) Vaccine ...